Is amoxicillin-clavulanate (Augmentin) with fluoroquinolone (ciprofloxacin or ofloxacin) eye drops recommended for treating bilateral conjunctivitis and otitis media in a 12-month-old, rather than amoxicillin with neomycin (Neosporin) and polymyxin B eye drops?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Bilateral Conjunctivitis and Otitis Media in a 12-Month-Old

For a 12-month-old with bilateral conjunctivitis and otitis media, amoxicillin-clavulanate (Augmentin) with fluoroquinolone eye drops is the recommended treatment regimen rather than amoxicillin with neomycin/polymyxin B eye drops. 1

Systemic Antibiotic Selection

  • Amoxicillin-clavulanate is the first-line treatment for children with concurrent otitis media and conjunctivitis (otitis-conjunctivitis syndrome) due to the likelihood of β-lactamase producing organisms 2, 1
  • High-dose amoxicillin-clavulanate (90 mg/kg/day of amoxicillin with 6.4 mg/kg/day of clavulanate in 2 divided doses) is specifically recommended for children with otitis-conjunctivitis syndrome 2
  • The American Academy of Pediatrics explicitly states that amoxicillin-clavulanate should be used instead of amoxicillin alone in children with concurrent conjunctivitis 1
  • Clinical studies show high efficacy rates (>90%) with amoxicillin-clavulanate for treating bilateral otitis media in young children 3

Rationale for Amoxicillin-Clavulanate Over Amoxicillin

  • Bilateral otitis media in children under 2 years requires aggressive antibiotic therapy due to high failure rates with observation alone (NNT = 3) 2, 4
  • The otitis-conjunctivitis syndrome is often caused by Haemophilus influenzae, which frequently produces β-lactamase, requiring clavulanate for effective treatment 1
  • Clinical failure rates for bilateral AOM in young children are significantly lower with amoxicillin-clavulanate (21.7%) compared to placebo (46.3%) 2
  • Amoxicillin alone may be insufficient as many H. influenzae isolates produce β-lactamase enzyme, causing resistance to penicillins 2

Topical Treatment for Conjunctivitis

  • Fluoroquinolone eye drops (ciprofloxacin or ofloxacin) are preferred over neomycin/polymyxin B for conjunctivitis treatment 1
  • Fluoroquinolone drops provide excellent coverage against common conjunctivitis pathogens including H. influenzae and S. pneumoniae 1
  • Topical fluoroquinolones have demonstrated superior efficacy and safety compared to neomycin/polymyxin B combinations 5
  • Neomycin carries a risk of contact dermatitis and allergic reactions that fluoroquinolones do not 5

Treatment Duration and Monitoring

  • For a 12-month-old with bilateral otitis media, a standard 10-day course of amoxicillin-clavulanate is recommended 4, 1
  • Reassessment within 48-72 hours is necessary if symptoms worsen or fail to improve 1
  • Adequate pain management with acetaminophen or ibuprofen at age-appropriate doses should be provided 4
  • Persistent middle ear effusion is common after resolution of acute symptoms (60-70% at 2 weeks) and does not necessarily indicate treatment failure 1

Treatment Failure Considerations

  • If initial treatment fails, consider alternative antibiotics such as ceftriaxone (50 mg/kg IM daily for 3 days) 2, 1
  • Treatment failure is more common in children under 2 years with bilateral disease, making appropriate initial antibiotic selection crucial 2
  • Bacterial eradication rates with high-dose amoxicillin-clavulanate exceed 90% for both S. pneumoniae and H. influenzae, including resistant strains 3, 6

The combination of amoxicillin-clavulanate with fluoroquinolone eye drops provides optimal coverage for both the otitis media and conjunctivitis components of this clinical presentation, with higher efficacy than amoxicillin with neomycin/polymyxin B drops.

References

Guideline

Treatment for Bilateral Conjunctivitis and Bilateral Otitis Media in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Bilateral Otitis Media

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.